Wikisage, the free encyclopedia of the second generation, is digital heritage

Stiripentol: Difference between revisions

From Wikisage
Jump to navigation Jump to search
(→‎Links: 412182)
Line 5: Line 5:
==Dravet`s Syndrome==
==Dravet`s Syndrome==
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913306/pdf/i1535-7511-14-1-22.pdf Stiripentol for Dravet Syndrome: Is It Worth It?]<ref>https://static-content.springer.com/lookinside/art%3A10.1007%2Fs40263-012-0004-3/000.png</ref>
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913306/pdf/i1535-7511-14-1-22.pdf Stiripentol for Dravet Syndrome: Is It Worth It?]<ref>https://static-content.springer.com/lookinside/art%3A10.1007%2Fs40263-012-0004-3/000.png</ref>
<ref>[http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/epdf Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders]</ref><ref>[http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2006.00497.x/pdf Stiripentol, a Putative Antiepileptic Drug, Enhances the Duration
<ref>[http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/epdf Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders]</ref><ref>[http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2006.00497.x/pdf Stiripentol, a Putative Antiepileptic Drug, Enhances the Duration of Opening of GABAA-Receptor Channels]</ref><ref>http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000664/WC500036518.pdf</ref><ref>http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2011.03008.x/epdf</ref>
of Opening of GABAA-Receptor Channels]</ref><ref>http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/000664/WC500036518.pdf</ref><ref>http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2011.03008.x/epdf</ref>


<gallery>
<gallery>

Revision as of 02:59, 1 July 2016